A survey of South Carolina pharmacists' readiness to prescribe human immunodeficiency virus pre-exposure prophylaxis
- PMID: 37251085
- PMCID: PMC10210504
- DOI: 10.1002/jac5.1773
A survey of South Carolina pharmacists' readiness to prescribe human immunodeficiency virus pre-exposure prophylaxis
Abstract
Introduction: HIV pre-exposure prophylaxis (PrEP) is largely underutilized in the Southern United States. Given their community presence, pharmacists are well positioned to provide PrEP within rural, Southern regions. However, pharmacists' readiness to prescribe PrEP in these communities remains unknown.
Objective: To determine the perceived feasibility and acceptability of prescribing PrEP by pharmacists in South Carolina (SC).
Methods: We distributed a 43-question online descriptive survey through the University of SC Kennedy Pharmacy Innovation Center's listerv of licensed SC pharmacists. We assessed pharmacists' comfort, knowledge, and readiness to provide PrEP.
Results: A total of 150 pharmacists responded to the survey. The majority were White (73%, n=110), female (62%, n=93), and non-Hispanic (83%, n=125). Pharmacists practiced in retail (25%, n=37), hospital (22%, n=33), independent (17%, n=25), community (13%, n=19), specialty (6%, n=9), and academic settings (3%, n=4); 11% (n=17) practiced in rural locales. Pharmacists viewed PrEP as both effective (97%, n=122/125) and beneficial (74% n=97/131) for their clients. Many pharmacists reported being ready (60% n=79/130) and willing (86% n=111/129) to prescribe PrEP, although over half (62% n=73/118) cited lack of PrEP knowledge as a barrier. Pharmacists described pharmacies as an appropriate location to prescribe PrEP (72% n=97/134).
Conclusions: Most SC pharmacists surveyed considered PrEP to be effective and beneficial for individuals who frequent their pharmacy and are willing to prescribe this therapy if statewide statutes allow. Many felt that pharmacies are an appropriate location to prescribe PrEP but lack a complete understanding of required protocols to manage these patients. Further investigation into facilitators and barriers of pharmacy-driven PrEP are needed to enhance utilization within communities.
Keywords: HIV Prevention; Pharmacists; PrEP; South Carolina; Southern United States.
Conflict of interest statement
DECLARATION OF CONFLICTS OF INTEREST All other authors declare no conflicts of interest.
Figures
References
-
- Centers for Disease Control and Prevention. HIV Surveillance Report: Statistics Overivew. https://www.cdc.gov/hiv/statistics/overview/index.html. Accessed July 30, 2021.
-
- Centers for Disease Control and Prevention. Diagnosis of HIV Infection in the United States and Dependent Areas, 2017. HIV Surveillance Report, vol. 29. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveil.... Accessed May 12, 2019.
-
- US Department of Health and Human Services. Ending the HIV Epidemic: About Ending the HIV Epidemic in the US: Overview. https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview. Accessed July 30 2021.
-
- Siegler AJ, Mouhanna F, Giler RM, Weiss K, Pembleton E, Guest J, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28(12):841–9. Epub 2018/07/10. doi: 10.1016/j.annepidem.2018.06.005. - DOI - PMC - PubMed
-
- US Department of Health and Human Services. Ending the HIV Epidemic: About Ending the HIV Epidemic in the US: Priority Jurisdictions: Phase I. https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/jurisdictio.... Accessed July 30 2021.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous